Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing
Amélie Bourhis(Centre Hospitalier Régional Universitaire de Brest), Arnaud Uguen(Inserm)
Cited by 15